| PERIOD ENDING | 31-Jan-07 | 31-Jan-06 | 31-Jan-05 | | Total Revenue | 119,361 | 131,525 | 124,249 | | Cost of Revenue | 106,555 | 108,474 | 103,525 | | | Gross Profit | 12,806 | 23,051 | 20,724 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 27,035 | 22,305 | 22,866 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,229) | 746 | (2,142) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 464 | 76 | | Earnings Before Interest And Taxes | (14,228) | 1,210 | (2,108) | | Interest Expense | 961 | 105 |
-
| | Income Before Tax | (15,189) | 1,105 | (2,108) | | Income Tax Expense | (695) | 71 | 121 | | Minority Interest |
-
| (10) | (42) | | | | Net Income From Continuing Ops | (14,494) | 1,024 | (2,229) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,494) | 1,024 | (2,229) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,494) | $1,024 | ($2,229) |
|
0.28% Nasdaq 
Income Statement
